Published in Br J Pharmacol on October 04, 2004
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol (2013) 5.74
5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice. J Neurosci (2009) 2.21
Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity. Gastroenterology (2012) 2.11
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther (2012) 1.79
Serotonin pharmacology in the gastrointestinal tract: a review. Naunyn Schmiedebergs Arch Pharmacol (2008) 1.18
Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation. Neurogastroenterol Motil (2009) 1.14
Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome. Tech Coloproctol (2014) 1.02
Behavioural and new pharmacological treatments for constipation: getting the balance right. Gut (2010) 1.01
Serotonin and neuroprotection in functional bowel disorders. Neurogastroenterol Motil (2007) 1.00
Evaluation and management of dyspepsia. Therap Adv Gastroenterol (2010) 0.89
Porcine left atrial and sinoatrial 5-HT(4) receptor-induced responses: fading of the response and influence of development. Br J Pharmacol (2006) 0.89
The in vitro pharmacological profile of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.88
The Pharmacology of TD-8954, a Potent and Selective 5-HT(4) Receptor Agonist with Gastrointestinal Prokinetic Properties. Front Pharmacol (2011) 0.86
The in vivo gastrointestinal activity of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.86
Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro. Br J Pharmacol (2007) 0.82
Inhibition of colonic motility and defecation by RS-127445 suggests an involvement of the 5-HT2B receptor in rodent large bowel physiology. Br J Pharmacol (2009) 0.81
A hybrid structural approach to analyze ligand binding by the serotonin type 4 receptor (5-HT4). Mol Cell Proteomics (2013) 0.81
The effect of tegaserod on esophageal submucosal glands bicarbonate and mucin secretion. Dig Dis Sci (2008) 0.81
Tegaserod mimics the neurostimulatory glycan polysialic acid and promotes nervous system repair. Neuropharmacology (2013) 0.80
Alosetron, cilansetron and tegaserod modify mesenteric but not colonic blood flow in rats. Br J Pharmacol (2009) 0.79
A comparison of the pharmacological properties of guinea-pig and human recombinant 5-HT4 receptors. Br J Pharmacol (2007) 0.79
New treatment options for chronic constipation: mechanisms, efficacy and safety. Can J Gastroenterol (2011) 0.77
Divergent changes to muscarinic and serotonergic signalling following colitis. Gut (2005) 0.77
5-HTR3 and 5-HTR4 located on the mitochondrial membrane and functionally regulated mitochondrial functions. Sci Rep (2016) 0.75
The inability of tegaserod to affect platelet aggregation and coronary artery tone at supratherapeutic concentrations. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.75
Choledochoscope manometry about different drugs on the Sphincter of Oddi. World J Gastroenterol (2008) 0.75
Effects of tegaserod on bile composition and hepatic secretion in Richardson ground squirrels on an enriched cholesterol diet. Lipids Health Dis (2006) 0.75
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol (1973) 47.81
Some quantitative uses of drug antagonists. Br J Pharmacol Chemother (1959) 41.90
5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine. Gastroenterology (1998) 1.78
Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells. Br J Pharmacol (1999) 1.67
Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain. Br J Pharmacol (1993) 1.56
Propulsion in guinea pig colon induced by 5-hydroxytryptamine (HT) via 5-HT4 and 5-HT3 receptors. J Pharmacol Exp Ther (1999) 1.47
The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors. Br J Pharmacol (1995) 1.41
The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound. Eur J Pharmacol (2001) 1.23
5-HT receptor classification and nomenclature: towards a harmonization with the human genome. Neuropharmacology (1997) 1.22
In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties. Br J Pharmacol (1996) 1.14
Serotonin and the 5-HT(2B) receptor in the development of enteric neurons. J Neurosci (2000) 1.11
5-HT(2A) receptors: location and functional analysis in intestines of wild-type and 5-HT(2A) knockout mice. Am J Physiol Gastrointest Liver Physiol (2002) 1.09
Characterization of the contraction to 5-HT in the canine colon longitudinal muscle. Br J Pharmacol (1997) 1.08
Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects. Aliment Pharmacol Ther (2003) 1.05
The guinea-pig distal colon--a sensitive preparation for the investigation of 5-HT4 receptor-mediated contractions. Br J Pharmacol (1993) 1.05
Functional consequence of serotonin/5-HT2B receptor signaling in heart: role of mitochondria in transition between hypertrophy and heart failure? Circulation (2003) 1.02
The importance of 5-hydroxytryptamine receptors in the gut. Pharmacol Ther (1995) 1.00
SDZ HTF 919 stimulates canine colonic motility and transit in vivo. J Pharmacol Exp Ther (1997) 1.00
Review article: tegaserod. Aliment Pharmacol Ther (2001) 0.99
Differences in signal transduction of two 5-HT4 receptor splice variants: compound specificity and dual coupling with Galphas- and Galphai/o-proteins. Mol Pharmacol (2002) 0.97
RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist. Br J Pharmacol (1999) 0.97
Identification of 5HT2-receptors on longitudinal muscle of the guinea pig ileum. J Recept Res (1984) 0.95
Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci (1991) 0.95
Pharmacological characterization of 5-HT4 receptors mediating relaxation of canine isolated rectum circular smooth muscle. Br J Pharmacol (1999) 0.95
Treatment of chronic constipation with cisapride and placebo. Gut (1987) 0.93
5-HT(2B) receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitro. Br J Pharmacol (2002) 0.93
Novel discriminatory ligands for 5-HT2B receptors. Behav Brain Res (1996) 0.92
SB-207266: 5-HT4 receptor antagonism in human isolated gut and prevention of 5-HT-evoked sensitization of peristalsis and increased defaecation in animal models. Neurogastroenterol Motil (1998) 0.89
N-[(1-butyl-4-piperidinyl)methyl]-3,4dihydro-2H-[1,3]oxazino[3,2- a]indole10-carboxamide hydrochloride: the first potent and selective 5-HT4 receptor antagonist amide with oral activity. J Med Chem (1995) 0.89
Effects of mosapride citrate, a 5-HT4 receptor agonist, on colonic motility in conscious guinea pigs. Jpn J Pharmacol (2002) 0.89
Effects of tegaserod on ileal peristalsis of guinea pig in vitro. J Pharmacol Sci (2004) 0.88
Human colonic mucosa possesses a mixed population of 5-HT receptors. Eur J Pharmacol (1996) 0.88
Inhibitory effect of 5-hydroxytryptamine on rat stomach fundus: mediated indirectly by activation of noradrenaline release. J Pharm Pharmacol (1995) 0.87
The serotonin 5-HT4 receptor. 2. Structure-activity studies of the indole carbazimidamide class of agonists. J Med Chem (1995) 0.87
Signal transduction pathways for serotonin as an intestinal secretagogue. Comp Biochem Physiol A Physiol (1997) 0.87
Cisapride in the management of chronic functional dyspepsia: a multicenter, double-blind, placebo-controlled study. Clin Ther (1987) 0.84
Gastrointestinal motility stimulating drugs and 5-HT receptors on myenteric neurons. Eur J Pharmacol (1989) 0.83
Genomic organisation and functional expression of the gene encoding the human serotonin 5-HT2C receptor. Eur J Pharmacol (1994) 0.82
Multiple-dose pharmacokinetics confirm no accumulation and dose proportionality of the novel promotile drug tegaserod (HTF 919). Eur J Clin Pharmacol (2001) 0.79
High affinity of SDZ HTF-919 related molecules for calf and human caudate 5-HT4 receptors. Ann N Y Acad Sci (1998) 0.77
Gene conversion tracts from double-strand break repair in mammalian cells. Mol Cell Biol (1998) 4.46
Guidelines for radiologically guided lung biopsy. Thorax (2003) 2.91
An iron-regulated ferric reductase associated with the absorption of dietary iron. Science (2001) 2.90
Mechanical closure of the vocal cords with the laryngeal mask airway ProSeal. Br J Anaesth (2002) 2.74
Evaluation of the relationship between laboratory and clinical tests of transversus abdominis function. Physiother Res Int (1996) 2.32
The Ypt1 GTPase is essential for the first two steps of the yeast secretory pathway. J Cell Biol (1995) 2.21
Synthesis of the membrane fusion and hemagglutinin proteins of measles virus, using a novel baculovirus vector containing the beta-galactosidase gene. J Virol (1990) 2.17
Errors in general practice: development of an error classification and pilot study of a method for detecting errors. Qual Saf Health Care (2003) 2.14
Selective disturbance of movement vision after bilateral brain damage. Brain (1983) 2.08
Adolescents' self-reported suicide attempts, self-harm thoughts and their correlates across 17 European countries. J Child Psychol Psychiatry (2011) 1.89
The nucleotide sequence of the mRNA encoding the fusion protein of measles virus (Edmonston strain): a comparison of fusion proteins from several different paramyxoviruses. Virology (1986) 1.76
Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia. Leuk Lymphoma (2006) 1.74
Reliability of drug dependents' self-reports. Drug Alcohol Depend (1997) 1.73
A redrawn Vandenberg and Kuse mental rotations test: different versions and factors that affect performance. Brain Cogn (1995) 1.71
Post-translational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. Biochem J (2001) 1.69
Regulation of ribosomal S6 kinase 2 by effectors of the phosphoinositide 3-kinase pathway. J Biol Chem (2000) 1.68
Survey of the prevalence, diagnosis and treatment of dermatological conditions in small animals in general practice. Vet Rec (2006) 1.64
Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: the role of Helicobacter pylori. Am J Gastroenterol (1993) 1.61
Nitric oxide mediates a therapeutic effect of nicotine in ulcerative colitis. Aliment Pharmacol Ther (2000) 1.55
Cotside measurement of cerebral blood flow in ill newborn infants by near infrared spectroscopy. Lancet (1988) 1.50
Effects of indomethacin on cerebral haemodynamics in very preterm infants. Lancet (1990) 1.50
Dexmedetomidine does not alter the sweating threshold, but comparably and linearly decreases the vasoconstriction and shivering thresholds. Anesthesiology (1997) 1.49
Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J Am Acad Dermatol (2001) 1.49
Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins. Virology (1992) 1.48
Effects of cognitive treatment in psychiatric rehabilitation. Schizophr Bull (1999) 1.43
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
PPAR alpha is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue. Proc Natl Acad Sci U S A (2002) 1.39
Purification and properties of carboxypeptidase G 1 . J Biol Chem (1971) 1.35
Cell proliferation in normal epidermis. J Invest Dermatol (1984) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
The effects of digital anaesthesia on predictive grip force adjustments during vertical movements of a grasped object. Eur J Neurosci (2001) 1.31
Pregnancy in a patient with a prosthetic mitral valve. Associated with a fetal anomaly attributed to warfarin sodium. JAMA (1968) 1.28
Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia. Am J Psychiatry (1998) 1.27
Ribosomal initiation at alternate AUGs on the Sendai virus P/C mRNA. J Virol (1986) 1.26
Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge. J Virol (1991) 1.24
BCR/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress. Leukemia (2008) 1.21
Role of smoking in inflammatory bowel disease: implications for therapy. Postgrad Med J (2000) 1.20
Intracellular processing, glycosylation, and cell-surface expression of the measles virus fusion protein (F) encoded by a recombinant adenovirus. Virology (1990) 1.19
Serotonin pharmacology in the gastrointestinal tract: a review. Naunyn Schmiedebergs Arch Pharmacol (2008) 1.18
Skin photosensitivity and photodestruction of several potential photodynamic sensitizers. Photochem Photobiol (1989) 1.17
Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha 2 adrenergic receptor. Anesthesiology (1988) 1.16
Partial sequence analysis of Xenopus alpha- and beta-globin mRNA as determined from recombinant DNA plasmids. Dev Biol (1980) 1.14
Bovine virus diarrhoea-mucosal disease virus: pathogenicity for the fetal calf following maternal infection. Vet Rec (1980) 1.14
Inhibition of dihydropteroate synthetase from Escherichia coli by sulfones and sulfonamides. Antimicrob Agents Chemother (1973) 1.13
Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains. Vaccine (2001) 1.11
Troglitazone causes acute mitochondrial membrane depolarisation and an AMPK-mediated increase in glucose phosphorylation in muscle cells. Diabetologia (2005) 1.11
Secretion of functional papain precursor from insect cells. Requirement for N-glycosylation of the pro-region. J Biol Chem (1990) 1.10
Techniques and trouble-shooting in high spatial resolution thin slice MRI for rectal cancer. Br J Radiol (2005) 1.10
Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone. Arthritis Rheum (2000) 1.07
Drug-like annotation and duplicate analysis of a 23-supplier chemical database totalling 2.7 million compounds. J Chem Inf Comput Sci (2004) 1.07
Techniques for active lumbar stabilisation for spinal protection: A pilot study. Aust J Physiother (2014) 1.07
Dihydropteroate synthetase from Plasmodium berghei: isolation, properties, and inhibition by dapsone and sulfadiazine. Mol Pharmacol (1974) 1.07
Ablation of human nail by pulsed lasers. Lasers Surg Med (1997) 1.07
MRI study of the size, symmetry and function of the trunk muscles among elite cricketers with and without low back pain. Br J Sports Med (2007) 1.06
Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study. Arch Dermatol (1997) 1.06
Study of apoptosis and heat shock protein (HSP) expression in hepatocytes following radiofrequency ablation (RFA). J Surg Res (2005) 1.05
Cell kinetic basis for pathophysiology of psoriasis. J Invest Dermatol (1985) 1.05
Towards a measurement of active muscle control for lumbar stabilisation. Aust J Physiother (2014) 1.05
A computational procedure for movement analysis in handwriting. J Neurosci Methods (1994) 1.05
The retarded child as a reinforcing agent. J Exp Child Psychol (1967) 1.04
Giant epidermoid cyst of penis. Urology (1979) 1.04
Species and response dependent differences in the effects of MAPK inhibitors on P2X(7) receptor function. Br J Pharmacol (2006) 1.03
The appearances of oesophageal carcinoma demonstrated on high-resolution, T2-weighted MRI, with histopathological correlation. Eur Radiol (2006) 1.01
Etoposide and illegitimate DNA double-strand break repair in the generation of MLL translocations: new insights and new questions. DNA Repair (Amst) (2006) 1.01
Transfer and expression of the human multiple drug resistance gene into live mice. Proc Natl Acad Sci U S A (1992) 1.01
Trustworthy reuse of health data: a transnational perspective. Int J Med Inform (2012) 1.01
An initial evaluation of eight abdominal exercises for their ability to provide stabilisation for the lumbar spine. Aust J Physiother (2014) 1.01
Postural stability of diabetic patients with and without cutaneous sensory deficit in the foot. Diabetes Res Clin Pract (1997) 1.01
Disturbance of movement vision after bilateral posterior brain damage. Further evidence and follow up observations. Brain (1991) 1.00
Effects of unilateral brain damage on grip selection, coordination, and kinematics of ipsilesional prehension. Exp Brain Res (1999) 0.99
Rheumatoid arthritis of the elbow: The results of synovectomy. J Bone Joint Surg Br (1974) 0.99
Targeted transgenesis. Proc Natl Acad Sci U S A (1996) 0.99
High and low affinity binding sites for concanavalin A on normal human fibroblasts in vitro. Biochem Biophys Res Commun (1977) 0.99
Neuromuscular responses to disturbance of balance in children with prenatal exposure to alcohol. Alcohol Clin Exp Res (1998) 0.99
Soluble CD14 enriched in colostrum and milk induces B cell growth and differentiation. Proc Natl Acad Sci U S A (2001) 0.98
Clinical sonography in urology. Urology (1973) 0.98
Dissociation of leptin secretion and adiposity during prehibernatory fattening in little brown bats. Am J Physiol Regul Integr Comp Physiol (2000) 0.97
RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist. Br J Pharmacol (1999) 0.97
Cold hands, warm heart. Lancet (1998) 0.97
Molecular identification of SqKv1A. A candidate for the delayed rectifier K channel in squid giant axon. J Gen Physiol (1996) 0.96
Functional analysis of N-linked glycosylation mutants of the measles virus fusion protein synthesized by recombinant vaccinia virus vectors. J Virol (1994) 0.96
Identification and sequencing of the spheroidin gene of Choristoneura biennis entomopoxvirus. Virology (1990) 0.96
Primary structure of an oligomeric antigen of Treponema pallidum. Infect Immun (1989) 0.95
Measurement of hemoglobin flow and blood flow by near-infrared spectroscopy. J Appl Physiol (1985) (1993) 0.94
Impaired ex vivo lipopolysaccharide-stimulated whole blood tumor necrosis factor production may identify "septic" intensive care unit patients. Shock (2000) 0.94
Cytokinetics in diseases of epidermal hyperplasia. Annu Rev Med (1973) 0.94
Regular gaming behavior and internet gaming disorder in European adolescents: results from a cross-national representative survey of prevalence, predictors, and psychopathological correlates. Eur Child Adolesc Psychiatry (2014) 0.93
Carotid endarterectomy after a completed stroke: reduction in long-term neurologic deterioration. J Vasc Surg (1985) 0.93
EMG study of erector spinae and multifidus in two isometric back extension exercises. Aust J Physiother (2014) 0.93
Mid-infrared laser ablation of stratum corneum enhances in vitro percutaneous transport of drugs. J Invest Dermatol (1991) 0.92
Prehension with the ipsilesional hand after unilateral brain damage. Cortex (1999) 0.92
Characteristic MR lesion pattern and correlation of T1 and T2 lesion volume with neurologic and neuropsychological findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). AJNR Am J Neuroradiol (1999) 0.92
Topical drug effects on normal and proliferating epidermal cell models. Arch Dermatol (1981) 0.92
Somatostatin analogue treatment inhibits post-resectional adaptation of the small bowel in rats. Am J Surg (1991) 0.92
Factors affecting Low Level Laser Therapy. Aust J Physiother (2014) 0.91
Mutation of glutamate 309 to glutamine alters one Ca(2+)-binding site in the Ca(2+)-ATPase of sarcoplasmic reticulum expressed in Sf9 cells. J Biol Chem (1993) 0.91
Interpretation of lung function tests in the sickle-cell haemoglobinopathies. Thorax (1978) 0.91
Mineral phases of calcium phosphate. Anat Rec (1989) 0.91
Cell proliferation kinetics of epidermis in the essential fatty acid deficient rat. J Invest Dermatol (1978) 0.91
A group programme for postnatally distressed women and their partners. J Adv Nurs (1997) 0.90